Thursday, March 30, 2017
Tags Valence Life Sciences

Tag: Valence Life Sciences


Popular Articles

Trea Direct Lending eyes second fundraise this year after €70m Fund I final close

Spanish investment firm Trea Direct Lending is already eyeing a second fundraise this year after announcing a €70m final close for its debut vehicle.

Russian Direct Investment Fund backs security business InfoWatch

Russia’s sovereign wealth fund Russian Direct Investment Fund has backed information security business InfoWatch group.

NPM Capital, investment trio invest €100m in fledgling Dutch online supermarket Picnic

NPM Capital and a trio of other Dutch investment houses have provided €100m of capital to fledgling online supermarket Picnic.

True North backs Indian hospital chain KIMS with $200m

Indian private equity firm True North has backed domestic hospital chain Kerala Institute of Medical Sciences (KIMS) with a $200m investment.

Endeavour bags minority stake in strategic advisory business Berkeley Research Group

Endeavour Capital has paid $62.5m for a minority stake in strategic advisory and consulting firm Berkeley Research Group.

Advent exits Corialis to CVC at an enterprise value of €1bn

Global private equity firm Advent International has exited Corialis, with CVC Capital Partners tapping its sixth fund to acquire the company. This deal gives Belgium-based...

Ashton Kutcher, Guy Oseary hire new managing partner for venture firm

Hollywood actor Ashton Kutcher and talent manager Guy Oseary’s venture capital firm Sound Ventures has named Effie Epstein as new managing partner and COO.

What impact will Article 50 have on private equity?

With British Prime Minister Theresa May triggering article 50 on Wednesday, questions still remain over what the EU UK economy and investment markets with look like post Brexit.

KRG scores another exit from ageing Fund IV with PAS International sale

KRG Capital has scored the eleventh exit from its $1.96bn fourth fund through the sale of 2010 investment PAS International to StandardAero.

Epiris nabs 6.5x return through Treetops Nurseries sale

London-based private equity firm Epiris has scored a 6.5-times return through the sale of Treetops Nurseries.